Neuropsychological dysfunctions in personality borderline disorder: Detection strategies

Actas Espanolas de Psiquiatria

Volumn 37, Issue 4, 2009, Pages 185-190

  Arza, R ^b   Diaz Marsa M ^b   Lopez Mico C ^b   De Fernandez Pablo N ^b   Lopez lbor J J ^b   Carrasco, J L ^a  

^a Salud Mental Hospital Clinico San Carlos   (Brazil)

^b CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED DE SALUD MENTAL CIBERSAM   (Spain)

Author keywords

Borderline personality disorder; Neuropsychological alterations

Indexed keywords

ARTICLE; BORDERLINE STATE; COGNITIVE DEFECT; FEMALE; HUMAN; MALE; NEUROPSYCHOLOGICAL TEST; PSYCHOLOGICAL ASPECT;

BORDERLINE PERSONALITY DISORDER; COGNITION DISORDERS; FEMALE; HUMANS; MALE; NEUROPSYCHOLOGICAL TESTS;

EID: 75349100882     PISSN: 11399287     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. 1. Swartz M, Blazer D, George L, Winfield I. Estimating the prevalence of borderline personality disorder in the communit. J Personal Disord 1990;4(3):257-272 (Pubitemid 20314209)
2. Burrguess JW. Relationship of depression and cognitive impairment to self-injury in borderline personality disorder, major depression, and schizophrenia. Psychiatry Res 1991 ;38:77-87.
3. Lahmeyer HW, Reynold CF III, Kupfer DJ, King. R. Biological markers in borderline personality disorder. J Clin Psychiatry 1989; 50:217-225
4. O'Leary KM, Brouwers P, Gardner DL Neuropsychology testing of patients with borderline personality disorder. AM J Psychatry 1991;148:106-111
5. 5. Skodol AE, Siever U, Livesley WJ, Gunderson JG, Pfohl B, Widiger TA. The bordeline diagnosis II: biology, genetics and clinical course. Biol Psychiatry 2002; 51(12):951-963 (Pubitemid 34607711)
6. Andrulonis PA, Glueck BC, Stroebel CF, Vogel NG, Shapiro AL, Aldridge DM. Organic brain dysfunction and the borderline sindrome. Psychitr Clin North Am 1980;4:7-66.
7. Van Reekum R. Acquired and developmental brain dysfunction in borderline personality disorder. Can J Psychiatry 1993;38(Suppl.1):4-10.
8. Cornelius JR, Soloff PH, George A, Ulrich RF, Perel JM. Halperidol vs phenelfine in continuation therapy of borderline disorder. Psychopharmacol Bull 1993;29(2):337-347
9. 9. Dunn NJ, Yanasak E, Schillaci J, Simotas S, Rehm LP, Souchek J, et al. Personality Disorders in Veterans with Posttraumatic Stress Disorder and Depression. Journal of traumatic stress 2004;1:75-82. (Pubitemid 38280768)
10. 10. Bazanis E, Rogers RD, Dowson JH, Taylor P, Meux C, Staley C, et al. Neurocognitive déficits in decision-making and planning of pacients with DSM-III-R borderline personality disorder. Psychol Med 2002;32(8):1395-1405 (Pubitemid 35385650)
11. Ruocco AC. The neuropsychology of borderline personality disorder: A meta-analysis and review. Psychiatry Res 2005;137(3):191202.
12. Ruocco AC, Swirsky-Sacchetti T, Chute DL Mandel S, Platek SM, Zillmer EA. Distinguishing between neuropsychological malingering and exaggerated psychiatric symptoms in a neuropsychological setting. Clin Neuropsychol 2008;22(3):547-564
13. Soloff PH, Meltzer CC, Becker C, Greer PJ, Kelly TM, Constantine D. Impulsivity and prefrontal hypometabolism in borderline personality disorder. Psychiatry Res 2003;123(3):153-163
14. 14. Minzenberg MJ, Fan J, New AS, Tang CY, Siever U. Frontolimbic structural changes in borderline personality disorder. J Psychiatr Res 2008;42(9):727-733 (Pubitemid 351636097)
15. 15. Matsui M, Sumiyoshi T, Kato K, Yoneyama E, Kurachi M. Neuropsychological profile in patients with schizotypal personality disorder or schizophrenia. Psychol Rep 2004;94(2):387-397 (Pubitemid 39109634)
16. 16. Herpertz SC, Schwenger UB, Kunert HJ, Lukas G, Gretzer U, Nutzmann J, Schuerkens A, Sass H. Emotional responses in patients with borderline as compared with avoidant personality disorder. J Personal Disord 2000 14(4)339-351 (Pubitemid 32060722)
17. 17. Corrigan FM, Davidson A, Heard H. The role of dysregulated amygdalic emotion in borderline personality disorder. Medical Hypotheses 2000 54(4), 574-579 (Pubitemid 30311546)
18. 18. Goyer PF, Andreason PJ, Semple WE, Clayton AH, King AC, Compton-Toth BA, et al. Positron emission tomography and personality disorders. Neuropsychopharmacology 1994;10:21-28 (Pubitemid 24074294)
19. 19. Penadés R, Catalán R, Salamero M, Boget T, Puig O, Guarch J, Gasto C. Cognitive remediation therapy for outpatients with chronic schizophrenia: a controlled and randomized study. Schizophr Res 2006;87:323-331 (Pubitemid 44428115)
20. 20. Paris J, Zelkowitz P, Guzder J, Joseph S, Feldman R. Neuropsychological factors associated with borderline pathology in children. J Am Acad Child Adolesc Psychiatry 1999;38:770-774 (Pubitemid 29250150)
21. Coolidge FL, Segal DL, Stewart SE, Ellett JAC. Neuropsychological dysfunction in children with borderline personality disorder features: a preliminary investigation. J Rers Pers 2000;34:554-561
22. Roder V, Brenner HD, Hodel B, Kienzle N. Terapia integrada de la esquizofrenia. Barcelona: Ariel Psiquiatria, 1996.
23. Wykes T, Reeder C. Cognitive remediation therapy for schizophrenia: theory and practice. 2005.